Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications-Reference-Cited by-同舟云学术

Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications

Published:2017-02-22 Issue:2 Volume:17 Page:109-119
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

De Oliveira Gustavo Laine Araujo¹²,Guerra Júnior Augusto Afonso¹³,Godman Brian⁴⁵,Acurcio Francisco de Assis¹³⁶

Affiliation:

1. Department of Social Pharmacy, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil

2. Department of Management and Incorporation of Health Technology, Ministry of Health, Brasilia, Brazil

3. SUS Collaborating Centre – Technology Assessment & Excellence in Health, School of Pharmacy, Federal University of Minas Gerais, Minas Gerais, Brazil

4. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

5. Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

6. School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2017.1292852

Reference55 articles.

1. World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016. p. 86.

2. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia

3. Brasil. Relação Nacional de Medicamentos Essenciais: RENAME 2014. 9th ed. Brasília: Ministério da Saúde; 2015. p. 228.

4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs;Metabolic Brain Disease;2023-06-19

2. Economic Evaluation of Type 2 Diabetes Mellitus Interventions in Low- and Middle-Income Countries: A Systematic Review of the Literature;Asia Pacific Journal of Public Health;2022-08-29

3. A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications;Clinical Diabetes;2022-07-01

4. Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions;Expert Review of Pharmacoeconomics & Outcomes Research;2022-04-04

5. Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review;Expert Review of Pharmacoeconomics & Outcomes Research;2022-02-18